Immunovant (IMVT)
NASDAQ:IMVT
Holding IMVT?
Track your performance easily

Immunovant (IMVT) Cash flow

761 Followers

Immunovant Cash Flow

IMVT's free cash flow for Q2 2025 was $-88.84M. For the 2025 fiscal year, IMVT's free cash flow was decreased by $-26.20M and operating cash flow was $-88.65M. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Operating Cash Flow
$ -284.61M$ -214.23M$ -188.19M$ -106.11M$ -83.33M$ -53.36M
Investing Cash Flow
$ -562.00K$ -360.00K$ -197.00K$ -254.00K$ -210.00K$ -31.00K
Financing Cash Flow
$ 3.11M$ 472.43M$ 70.89M$ 200.13M$ 383.11M$ 141.57M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.68B$ 376.53M$ 376.53M$ 400.15M$ 100.57M$ 95.16M
Income Tax Paid Supplemental Data
$ 810.00K$ 509.00K--$ 166.00K$ 61.00K
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
-----$ 32.50M
Repayment Of Debt
-----$ -2.50M
Free Cash Flow
$ -285.17M$ -214.59M$ -188.39M$ -106.37M$ -83.54M$ -53.39M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Immunovant Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis